The evidence brief

Peptide guides, graded honestly.

News on the FDA's peptide decisions, compound deep-dives, safety and legal explainers, and head-to-head comparisons — every claim cited, every peptide graded A–F by human evidence.

News

The 7 Peptides the FDA Decides On This July (PCAC Preview)

On July 23–24, 2026 the FDA's advisory committee votes on whether seven peptides — BPC-157, TB-500, KPV, MOTS-c, DSIP, Semax and Epitalon — can be legally compounded. What's at stake, and what the evidence actually says.

Jul 6, 20267 min read

Get the monthly peptide evidence brief.

What the research and the FDA actually say — one short email a month. Unsubscribe anytime.

No spam. We never sell your email. Editorial policy.